Yaschilal Muche Belayneh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yaschilal Muche Belayneh has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Birhanu Geta Meharie
Department of Pharmacy, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia
4 shared publications - Gedefaw Getnet Amare
Department of Pharmacy, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia
4 shared publications - Zemene Demelash Kifle
Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia
4 shared publications - Solomon Ahmed Mohammed
Department of Pharmacy, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia
3 shared publications - Abel Andualem
School of Pharmacy
2 shared publications Digambar Ambikar
Department of Pharmacology, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
2 shared publications
Latest Publications
- Open Access
- 20 August 2026
- Published by SAGE Publications in Annals of Neurosciences
GABA as an Overlooked Mediator of Metformin Action: GABA-mediated Neuropsychiatric and Hepatoprotective Activities of Metformin
Background: According to treatment guidelines, metformin is the first-line medication for type 2 diabetes. The neuropsychiatric and hepatoprotective activities of metformin, mediated by modulation of gamma-aminobutyric acid (GABA) signalling pathways, have recently attracted the attention of researchers. Summary: The objective of this narrative review is to compile the most recent data from original research on the GABA-mediated effects of metformin in a range of disorders. Original articles were searched from various electronic databases using relevant search terms. According to animal studies on rodent models of anxiety, metformin increases the intracellular level of AMP-activated protein kinase and GABAergic neurotransmission in the hippocampus and medial prefrontal cortex, resulting in anxiolytic effects. Similarly, metformin increased the levels of GABA and lowered the levels of glutamate in the hippocampus of diabetic epileptic rats. This action was associated with reduced neuroinflammation and apoptosis and improved cognitive function and seizure outcomes. Additionally, an open-label clinical trial with people who have Fragile X syndrome demonstrated that metformin is potentially an effective treatment, and it might improve GABA-mediated inhibition of the cortex as a mechanism. Moreover, beyond the neuropsychiatric action in the central nervous system, metformin reduced ferroptosis in a mouse model of hepatic ischemia/reperfusion injury, with GABA identified as a key microbiota-derived metabolite involved in hepatoprotection. Key Message: Animal and human studies showed that GABAergic signalling pathways are involved in neuropsychiatric and hepatoprotective activities of metformin. However, the available literature is still fragmented and mainly based on animal studies, suggesting the need for more detailed mechanistic studies and human studies.
- 20 August 2026
- Published by SAGE Publications in Annals of Neurosciences
Open AccessGABA as an Overlooked Mediator of Metformin Action: GABA-mediated Neuropsychiatric and Hepatoprotective Activities of Metformin
Background: According to treatment guidelines, metformin is the first-line medication for type 2 diabetes. The neuropsychiatric and hepatoprotective activities of metformin, mediated by modulation of gamma-aminobutyric acid (GABA) signalling pathways, have recently attracted the attention of researchers. Summary: The objective of this narrative review is to compile the most recent data from original research on the GABA-mediated effects of metformin in a range of disorders. Original articles were searched from various electronic databases using relevant search terms. According to animal studies on rodent models of anxiety, metformin increases the intracellular level of AMP-activated protein kinase and GABAergic neurotransmission in the hippocampus and medial prefrontal cortex, resulting in anxiolytic effects. Similarly, metformin increased the levels of GABA and lowered the levels of glutamate in the hippocampus of diabetic epileptic rats. This action was associated with reduced neuroinflammation and apoptosis and improved cognitive function and seizure outcomes. Additionally, an open-label clinical trial with people who have Fragile X syndrome demonstrated that metformin is potentially an effective treatment, and it might improve GABA-mediated inhibition of the cortex as a mechanism. Moreover, beyond the neuropsychiatric action in the central nervous system, metformin reduced ferroptosis in a mouse model of hepatic ischemia/reperfusion injury, with GABA identified as a key microbiota-derived metabolite involved in hepatoprotection. Key Message: Animal and human studies showed that GABAergic signalling pathways are involved in neuropsychiatric and hepatoprotective activities of metformin. However, the available literature is still fragmented and mainly based on animal studies, suggesting the need for more detailed mechanistic studies and human studies.
- Open Access
- 7 December 2025
- Published by SAGE Publications in Natural Product Communications
- Vol. 20 (12)
Ethnobotany, Ethnopharmacology, and Phytochemistry of Calpurnia aurea (Ait.) Benth. (Fabaceae): A Narrative Review
Calpurnia aurea is a yellow-flowered, multi-stemmed small tree or shrub that grows 3-4 meters tall and is widely distributed across Africa, from South Africa to Eritrea, and also found in southern India. This study aimed to document and synthesize the traditional medicinal uses, phytochemicals, and pharmacological properties of Calpurnia aurea . Relevant literature and information were collected from credible sources, including databases such as PubMed, ScienceDirect, Scopus, and Google Scholar. In Ethiopian traditional medicine, C. aurea is used to treat a wide range of health conditions, including wounds, giardiasis, malaria, diarrhea, rabies, diabetes, herpes zoster , external parasites, Tinea capitis , leishmaniasis, tapeworm infections, trachoma, ringworm, and hypertension. In addition to Ethiopia, South Africa and Nigeria have used this plant as a traditional treatment mostly for dermatological conditions. Quinolizidine alkaloids and flavonoids are the major phytochemicals that have been isolated from different parts of the plant. Both in vivo and in vitro studies have reported that C. aurea possesses a wide range of pharmacological activities, such as hepatoprotective, antibacterial, antidiarrheal, antidiabetic, antihypertensive, antitumor, wound-healing, antioxidant, anti-inflammatory, antifungal, acaricidal and anti-arthritic effects. Some of these activities are linked with ononin, maackiain, medicarpin, and virgiline-type quinolizidine alkaloids. Given the plant's notable chemical and pharmacological potential, further investigation of its remaining isolated compounds, particularly their bioactivities, structure-activity relationships, and safety profiles, could play a vital role in translating traditional medicinal knowledge into modern therapeutic discovery.
- 7 December 2025
- Published by SAGE Publications in Natural Product Communications
- Vol. 20 (12)
Open AccessEthnobotany, Ethnopharmacology, and Phytochemistry of Calpurnia aurea (Ait.) Benth. (Fabaceae): A Narrative Review
Calpurnia aurea is a yellow-flowered, multi-stemmed small tree or shrub that grows 3-4 meters tall and is widely distributed across Africa, from South Africa to Eritrea, and also found in southern India. This study aimed to document and synthesize the traditional medicinal uses, phytochemicals, and pharmacological properties of Calpurnia aurea . Relevant literature and information were collected from credible sources, including databases such as PubMed, ScienceDirect, Scopus, and Google Scholar. In Ethiopian traditional medicine, C. aurea is used to treat a wide range of health conditions, including wounds, giardiasis, malaria, diarrhea, rabies, diabetes, herpes zoster , external parasites, Tinea capitis , leishmaniasis, tapeworm infections, trachoma, ringworm, and hypertension. In addition to Ethiopia, South Africa and Nigeria have used this plant as a traditional treatment mostly for dermatological conditions. Quinolizidine alkaloids and flavonoids are the major phytochemicals that have been isolated from different parts of the plant. Both in vivo and in vitro studies have reported that C. aurea possesses a wide range of pharmacological activities, such as hepatoprotective, antibacterial, antidiarrheal, antidiabetic, antihypertensive, antitumor, wound-healing, antioxidant, anti-inflammatory, antifungal, acaricidal and anti-arthritic effects. Some of these activities are linked with ononin, maackiain, medicarpin, and virgiline-type quinolizidine alkaloids. Given the plant's notable chemical and pharmacological potential, further investigation of its remaining isolated compounds, particularly their bioactivities, structure-activity relationships, and safety profiles, could play a vital role in translating traditional medicinal knowledge into modern therapeutic discovery.
- Open Access
- 31 January 2025
- Published by SAGE Publications in Scars, Burns & Healing
- Vol. 11
Evaluation of wound healing activity of the crude extract and solvent fractions of Rumex nervosus Vahl (Polygonaceae) leaves in mice
Background: In Ethiopian traditional medicine, Rumex nervosus Vahl leaves are used to treat wounds. However, despite traditional claims and supportive in vitro findings, no scientific study has been conducted to evaluate the in vivo wound healing activity of R. nervosus Vahl leaves. Aim of the study: To evaluate the wound healing activity of crude extract of the leaves of R. nervosus Vahl and its solvent fractions in mice. Methods: R. nervosus Vahl leaves were extracted with 80% methanol, and then the crude extract was fractionated using ethyl acetate, chloroform, and water. Ointments at 5% and 10% strengths were formulated from the crude extract and its fractions. The healing activity of the crude extract was evaluated using linear incision, circular excision, and burn wound models in mice. Additionally, the activity of solvent fractions was assessed using circular excision wounds in mice. Results: Treatment of wounds with ointments containing 5% and 10% crude extract showed significantly increased wound contraction rate, shorter epithelialization period, and higher skin-breaking strength (P < 0.05) compared with the negative control. Both 5% and 10% formulations of the aqueous and ethyl acetate fractions significantly increased wound contraction and decreased the period of epithelialization in the excision wound model (p < 0.05), however, the chloroform fraction showed no significant wound healing effect compared with the negative control. Conclusion: The 80% methanol crude extract as well as the aqueous and ethyl acetate fractions of R. nervosus Vahl leaves possess wound healing activity as evidenced by improved wound contraction rate and tensile strength and decreased epithelialization period.
- 31 January 2025
- Published by SAGE Publications in Scars, Burns & Healing
- Vol. 11
Open AccessEvaluation of wound healing activity of the crude extract and solvent fractions of Rumex nervosus Vahl (Polygonaceae) leaves in mice
Background: In Ethiopian traditional medicine, Rumex nervosus Vahl leaves are used to treat wounds. However, despite traditional claims and supportive in vitro findings, no scientific study has been conducted to evaluate the in vivo wound healing activity of R. nervosus Vahl leaves. Aim of the study: To evaluate the wound healing activity of crude extract of the leaves of R. nervosus Vahl and its solvent fractions in mice. Methods: R. nervosus Vahl leaves were extracted with 80% methanol, and then the crude extract was fractionated using ethyl acetate, chloroform, and water. Ointments at 5% and 10% strengths were formulated from the crude extract and its fractions. The healing activity of the crude extract was evaluated using linear incision, circular excision, and burn wound models in mice. Additionally, the activity of solvent fractions was assessed using circular excision wounds in mice. Results: Treatment of wounds with ointments containing 5% and 10% crude extract showed significantly increased wound contraction rate, shorter epithelialization period, and higher skin-breaking strength (P < 0.05) compared with the negative control. Both 5% and 10% formulations of the aqueous and ethyl acetate fractions significantly increased wound contraction and decreased the period of epithelialization in the excision wound model (p < 0.05), however, the chloroform fraction showed no significant wound healing effect compared with the negative control. Conclusion: The 80% methanol crude extract as well as the aqueous and ethyl acetate fractions of R. nervosus Vahl leaves possess wound healing activity as evidenced by improved wound contraction rate and tensile strength and decreased epithelialization period.
- Open Access
- 21 January 2024
- Published by Elsevier in Metabolism Open
- Vol. 21, 100272
Evaluation of hepatoprotective and antidiarrheal activities of the hydromethanol crude extract and solvent fractions of Schinus molle L. (Anacardiaceae) leaf and fruit in mice
- 21 January 2024
- Published by Elsevier in Metabolism Open
- Vol. 21, 100272
Open AccessEvaluation of hepatoprotective and antidiarrheal activities of the hydromethanol crude extract and solvent fractions of Schinus molle L. (Anacardiaceae) leaf and fruit in mice
- Open Access
- 24 May 2022
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 22 (1) , 1-8
A cross-sectional study of herbal medicine use and contributing factors among pregnant women on antenatal care follow-up at Dessie Referral Hospital, Northeast Ethiopia
Background: Herbal medicines are widely used in the world especially in developing countries. Pregnant women use herbal products to treat pregnancy related illnesses due to prior experience of herbal medicine use and easy accessibility of the products with less cost. However, herbal products could affect fetal growth and contribute to maternal and fetal morbidity and mortality. Herbal drug use during pregnancy is not well studied in Ethiopia specifically in northeast Ethiopia. Methods: A cross-sectional survey was conducted among 254 pregnant women on antenatal care follow-up at Dessie referral hospital. Semi-structured questionnaires were used for data collection. After collection, data were coded, entered and analyzed by SPSS version 20. Chi squared test and Logistic regression were used to evaluate the association between dependent and independent variables. Result: Among the total of 254 respondents, 130 (51.2%) used herbal drugs during current pregnancy. The most commonly mentioned reason for herbal drug use was “herbal medicines are accessible without prescription” (43.1%). The herbal medicines used were Ginger (Zingiber officinale Roscoe) (43.8%), followed by Garlic (Allium sativum L.) (23.8%), Damakese (Ocimum lamiifolium Hochst. ex Benth.) (21.5%) and Tena-adam (Ruta chalepensis L.) (10.8%). The indications for herbal drug use were nausea/vomiting (43.8%), headache (30.8%) and common cold (25.4%). The most commonly mentioned sources of information on herbal medicine were families and friends (80.0%) followed by neighbors (12.3%), and the most commonly cited sources of herbal products were market (67.7%) and self-preparation (20.0%). Being illiterate or having only primary school education (Adjusted Odds Ratio [AOR]: 3.717, 95% CI: 0.992-13.928), having secondary school education background (AOR: 3.645, 95% CI: 1.394-9.534), and poor monthly income (AOR: 7.234, 95% CI: 2.192-23.877) were the variables that showed significant association with herbal drug use during current pregnancy. Conclusion: This study showed that half of the sampled pregnant women used herbal medicine during current pregnancy, and education status and monthly income level of the women were associated with herbal drug use.
- 24 May 2022
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 22 (1) , 1-8
Open AccessA cross-sectional study of herbal medicine use and contributing factors among pregnant women on antenatal care follow-up at Dessie Referral Hospital, Northeast Ethiopia
Background: Herbal medicines are widely used in the world especially in developing countries. Pregnant women use herbal products to treat pregnancy related illnesses due to prior experience of herbal medicine use and easy accessibility of the products with less cost. However, herbal products could affect fetal growth and contribute to maternal and fetal morbidity and mortality. Herbal drug use during pregnancy is not well studied in Ethiopia specifically in northeast Ethiopia. Methods: A cross-sectional survey was conducted among 254 pregnant women on antenatal care follow-up at Dessie referral hospital. Semi-structured questionnaires were used for data collection. After collection, data were coded, entered and analyzed by SPSS version 20. Chi squared test and Logistic regression were used to evaluate the association between dependent and independent variables. Result: Among the total of 254 respondents, 130 (51.2%) used herbal drugs during current pregnancy. The most commonly mentioned reason for herbal drug use was “herbal medicines are accessible without prescription” (43.1%). The herbal medicines used were Ginger (Zingiber officinale Roscoe) (43.8%), followed by Garlic (Allium sativum L.) (23.8%), Damakese (Ocimum lamiifolium Hochst. ex Benth.) (21.5%) and Tena-adam (Ruta chalepensis L.) (10.8%). The indications for herbal drug use were nausea/vomiting (43.8%), headache (30.8%) and common cold (25.4%). The most commonly mentioned sources of information on herbal medicine were families and friends (80.0%) followed by neighbors (12.3%), and the most commonly cited sources of herbal products were market (67.7%) and self-preparation (20.0%). Being illiterate or having only primary school education (Adjusted Odds Ratio [AOR]: 3.717, 95% CI: 0.992-13.928), having secondary school education background (AOR: 3.645, 95% CI: 1.394-9.534), and poor monthly income (AOR: 7.234, 95% CI: 2.192-23.877) were the variables that showed significant association with herbal drug use during current pregnancy. Conclusion: This study showed that half of the sampled pregnant women used herbal medicine during current pregnancy, and education status and monthly income level of the women were associated with herbal drug use.
- Open Access
- 1 May 2022
- Published by Taylor & Francis in Journal of Experimental Pharmacology
- Vol. ume 14, 167-183
Wound Healing Activity of 80% Methanolic Crude Extract and Solvent Fractions of the Leaves of Justicia schimperiana (Hochst. ex Nees) T. Anderson (Acanthaceae) in Mice
Introduction: Justicia schimperiana has been used traditionally for the treatment of wound and skin burn, but there is no scientific evidence that supports the traditional claim. Objective: To evaluate the wound healing activity of 80% methanol crude extract and solvent fractions of the leaves of Justicia schimperiana in mice. Methods: Mice were used for wound healing study, while rats were used for acute dermal toxicity test. The 80% methanol crude extract and chloroform, ethyl acetate and aqueous fractions were formulated in ointments with 5% and 10% strength. Burn, excision and incision wound models were used to evaluate the effect of the crude extract, whereas the activity of the solvent fractions was evaluated using excision wound model. Parameters such as wound contraction, and period of epithelialization were studied in the excision and burn wound models, while tensile strength was measured in incision wound model. Results: Treatment of wound with 80% methanol extract of Justicia schimperiana leaves using 5% (w/w) and 10% (w/w) ointment formulation induced significant (P< 0.05) improvement in wound contraction rate, epithelialization time and skin breaking strength in excision, incision and burn wound model, respectively as compared to negative control. The chloroform, ethyl acetate and aqueous fractions with 5% (w/w) and 10% (w/w) ointment formulation showed significant (p< 0.001) improvement in wound contraction and epithelialization time in excision wound model as compared to the negative control group. Conclusion: This study has demonstrated that the 80% methanol crude extract and solvent fractions of Justicia schimperiana leaves possess wound healing activity.
- 1 May 2022
- Published by Taylor & Francis in Journal of Experimental Pharmacology
- Vol. ume 14, 167-183
Open AccessWound Healing Activity of 80% Methanolic Crude Extract and Solvent Fractions of the Leaves of Justicia schimperiana (Hochst. ex Nees) T. Anderson (Acanthaceae) in Mice
Introduction: Justicia schimperiana has been used traditionally for the treatment of wound and skin burn, but there is no scientific evidence that supports the traditional claim. Objective: To evaluate the wound healing activity of 80% methanol crude extract and solvent fractions of the leaves of Justicia schimperiana in mice. Methods: Mice were used for wound healing study, while rats were used for acute dermal toxicity test. The 80% methanol crude extract and chloroform, ethyl acetate and aqueous fractions were formulated in ointments with 5% and 10% strength. Burn, excision and incision wound models were used to evaluate the effect of the crude extract, whereas the activity of the solvent fractions was evaluated using excision wound model. Parameters such as wound contraction, and period of epithelialization were studied in the excision and burn wound models, while tensile strength was measured in incision wound model. Results: Treatment of wound with 80% methanol extract of Justicia schimperiana leaves using 5% (w/w) and 10% (w/w) ointment formulation induced significant (P< 0.05) improvement in wound contraction rate, epithelialization time and skin breaking strength in excision, incision and burn wound model, respectively as compared to negative control. The chloroform, ethyl acetate and aqueous fractions with 5% (w/w) and 10% (w/w) ointment formulation showed significant (p< 0.001) improvement in wound contraction and epithelialization time in excision wound model as compared to the negative control group. Conclusion: This study has demonstrated that the 80% methanol crude extract and solvent fractions of Justicia schimperiana leaves possess wound healing activity.
- Open Access
- 14 October 2021
- Published by Elsevier in Metabolism Open
- Vol. 12, 100139
In vivo hypoglycemic, antihyperglycemic and antidyslipidemic effects of the solvent fractions of Hagenia abyssinica leaves in mice
- 14 October 2021
- Published by Elsevier in Metabolism Open
- Vol. 12, 100139
Open AccessIn vivo hypoglycemic, antihyperglycemic and antidyslipidemic effects of the solvent fractions of Hagenia abyssinica leaves in mice
- Open Access
- 1 September 2021
- Published by Elsevier in Metabolism Open
- Vol. 11, 100119
Evaluation of the antiulcerogenic activity of hydromethanol extracts of Solanum incanum L. (Solanaceae) leaves and roots in mice; single and repeated dose study
- 1 September 2021
- Published by Elsevier in Metabolism Open
- Vol. 11, 100119
Open AccessEvaluation of the antiulcerogenic activity of hydromethanol extracts of Solanum incanum L. (Solanaceae) leaves and roots in mice; single and repeated dose study
- Open Access
- 1 September 2021
- Published by Elsevier in Metabolism Open
- Vol. 11, 100098
A retrospective study of drug related problems and contributing factors among type 2 diabetes mellitus patients on follow up at public health institutions of kemisse town, north east Ethiopia
- 1 September 2021
- Published by Elsevier in Metabolism Open
- Vol. 11, 100098
Open AccessA retrospective study of drug related problems and contributing factors among type 2 diabetes mellitus patients on follow up at public health institutions of kemisse town, north east Ethiopia
- 11 January 2021
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 27 (4) , 954-961
Updates on the molecular mechanisms of aspirin in the prevention of colorectal cancer: Review
Colorectal cancer is one of the commonest malignancies worldwide. The estimated lifetime risk of the disease is about 5% with an incidence of one million new cases and 600,000 deaths worldwide every year. It is estimated that in 2019, approximately 134,490 new cases of colorectal cancer will be diagnosed with 49,190 mortalities. Though the disease is regarded as a disorder of the more developed world, the occurrence is steadily increasing in many developing countries. Since chronic inflammation is a known aggravating risk factor for colorectal cancer, anti-inflammatory agents such as aspirin have been used to prevent the development of colorectal cancer and related mortality. The potential mechanisms for the effect of aspirin in the prevention of colorectal cancer have been proposed and broadly classified as cyclooxygenase (COX) dependent and COX-independent. Some of the primary effectors of COX-dependent mechanisms in carcinogenesis are likely to be prostaglandins. In contrast to the reversible action of other nonsteroidal anti-inflammatory drugs, aspirin is known to irreversibly inactivate COX enzymes to suppress production of prostaglandins. COX-independent mechanisms of anticancer effects of aspirin include down-regulation of nuclear factor kappa B activity and Akt activation, modulation of Bcl-2 and Bax family proteins, suppression of vascular endothelial growth factor, induction of apoptosis, disruption of DNA repair mechanisms, and induction of spermidine/spermine N1-acetyltransferase that modulates polyamine catabolism.
- 11 January 2021
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 27 (4) , 954-961
Updates on the molecular mechanisms of aspirin in the prevention of colorectal cancer: Review
Colorectal cancer is one of the commonest malignancies worldwide. The estimated lifetime risk of the disease is about 5% with an incidence of one million new cases and 600,000 deaths worldwide every year. It is estimated that in 2019, approximately 134,490 new cases of colorectal cancer will be diagnosed with 49,190 mortalities. Though the disease is regarded as a disorder of the more developed world, the occurrence is steadily increasing in many developing countries. Since chronic inflammation is a known aggravating risk factor for colorectal cancer, anti-inflammatory agents such as aspirin have been used to prevent the development of colorectal cancer and related mortality. The potential mechanisms for the effect of aspirin in the prevention of colorectal cancer have been proposed and broadly classified as cyclooxygenase (COX) dependent and COX-independent. Some of the primary effectors of COX-dependent mechanisms in carcinogenesis are likely to be prostaglandins. In contrast to the reversible action of other nonsteroidal anti-inflammatory drugs, aspirin is known to irreversibly inactivate COX enzymes to suppress production of prostaglandins. COX-independent mechanisms of anticancer effects of aspirin include down-regulation of nuclear factor kappa B activity and Akt activation, modulation of Bcl-2 and Bax family proteins, suppression of vascular endothelial growth factor, induction of apoptosis, disruption of DNA repair mechanisms, and induction of spermidine/spermine N1-acetyltransferase that modulates polyamine catabolism.